--- title: "Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution" type: "News" locale: "en" url: "https://longbridge.com/en/news/293302624.md" description: "Amundi S.A. notified Bayer Aktiengesellschaft of a change in major holdings on July 14, 2026. The notification details a decrease in voting rights from 3.09% to 2.96%, corresponding to a reduction in total voting rights from the previous threshold to 98,242,408. This disclosure was issued under Article 40, Section 1 of the German Securities Trading Act for Europe-wide distribution." datetime: "2026-07-21T07:16:13.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293302624.md) - [en](https://longbridge.com/en/news/293302624.md) - [zh-HK](https://longbridge.com/zh-HK/news/293302624.md) --- # Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Bayer Aktiengesellschaft Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG \[the German Securities Trading Act\] with the objective of Europe-wide distribution 21.07.2026 / 09:16 CET/CEST Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. **Notification of Major Holdings****1\. Details of issuer** Name: Bayer Aktiengesellschaft Street: Kaiser-Wilhelm-Allee 1 Postal code: 51373 City: LeverkusenGermany Legal Entity Identifier (LEI): 549300J4U55H3WP1XT59 **2\. Reason for notification** X Acquisition/disposal of shares with voting rights   Acquisition/disposal of instruments   Change of breakdown of voting rights   Other reason: **3\. Details of person subject to the notification obligation** Legal entity: Amundi S.A.City of registered office, country: Paris, France **4\. Names of shareholder(s)** holding directly 3% or more voting rights, if different from 3.**5\. Date on which threshold was crossed or reached:** 14 Jul 2026 **6\. Total positions**   % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG New 2.96 % 0.00 % 2.96 % 982424082 Previous notification 3.09 % 0.00 % 3.09 % / **7\. Details on total positions** **a. Voting rights attached to shares (Sec. 33, 34 WpHG)** ISIN Absolute In %   Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) DE000BAY0017 0 29109432 0 % 2.96 % **Total** 29109432 2.96 % **b.1. Instruments according to Sec. 38 (1) no. 1 WpHG** Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % Securities lent (right to recall) 13770 0.00 %     **Total** 13770 0.00 % **b.2. Instruments according to Sec. 38 (1) no. 2 WpHG** Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % 0 0 %       **Total** 0 0.00 % **8\. Information in relation to the person subject to the notification obligation**   Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more) Amundi S.A. % % % Amundi Asset Management S.A.S. % % % \- % % % Amundi S.A. % % % CPR Asset Management S.A. % % % \- % % % Amundi S.A. % % % Amundi Asset Management S.A.S. % % % Amundi SGR SpA % % % \- % % % Amundi S.A. % % % Amundi Asset Management S.A.S. % % % Amundi Deutschland GmbH % % % \- % % % Amundi S.A. % % % Amundi Asset Management S.A.S. % % % Amundi Taiwan Ltd. % % % \- % % % Amundi S.A. % % % Amundi Asset Management S.A.S. % % % Amundi Investment Fund Management Private Limited Company % % % \- % % % Amundi S.A. % % % Amundi Asset Management S.A.S. % % % Amundi Japan Ltd. % % % \- % % % Amundi S.A. % % % Amundi Asset Management S.A.S. % % % SABADELL ASSET MANAGEMENT SA, SGIIC % % % \- % % % Amundi S.A. % % % Amundi Asset Management S.A.S. % % % Amundi Iberia SGIIC, SA % % % \- % % % Amundi S.A. % % % Amundi Asset Management S.A.S. % % % Amundi Ireland Ltd. % % % \- % % % **9\. In case of proxy voting according to Sec. 34 para. 3 WpHG** (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting: Proportion of voting rights % Proportion of instruments % Total of both % **10\. Other explanatory remarks:** Date 20 Jul 2026 21.07.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Language: English Company: Bayer Aktiengesellschaft Kaiser-Wilhelm-Allee 1 51373 Leverkusen Germany Internet: www.bayer.com LEI Code: 549300J4U55H3WP1XT59   End of News EQS News Service 2368922 21.07.2026 CET/CEST **Disclaimer** Saving the news in databases or any forwarding of the news to third parties in a commercial context or for commercial purposes is only permitted with the prior written consent of EQS Group AG. ### Related Stocks - [BAYN.DE](https://longbridge.com/en/quote/BAYN.DE.md) - [BAYRY.US](https://longbridge.com/en/quote/BAYRY.US.md) - [EQS.DE](https://longbridge.com/en/quote/EQS.DE.md) - [BAYZF.US](https://longbridge.com/en/quote/BAYZF.US.md) ## Related News & Research - [BAYN: Strong 2025 results, innovation focus, and €2bn cost savings drive improved financial outlook](https://longbridge.com/en/news/294831947.md) - [Bayer Swings to Net Profit on Smaller Litigation Charges](https://longbridge.com/en/news/294778020.md) - [BAYN: Q2 2026 delivered solid sales and EBITDA growth, but free cash flow was impacted by litigation](https://longbridge.com/en/news/294773093.md) - [Bayer seeks China approval to expand Kerendia use to non-diabetic chronic kidney disease](https://longbridge.com/en/news/294312597.md) - [Bayer plans 2027 launch of Bergkamen site-services operating unit](https://longbridge.com/en/news/294165865.md)